Literature DB >> 18682485

Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history.

Meira Epplein1, Susan D Reed, Lynda F Voigt, Katherine M Newton, Victoria L Holt, Noel S Weiss.   

Abstract

The authors sought to test the hypothesis that characteristics and exposures which influence the balance of estrogen and progesterone bear on the incidence of endometrial hyperplasia (EH), a noninvasive proliferation of the lining of the uterus. Cases included all female members of Group Health (Washington State) who were diagnosed with complex EH or EH with atypia during the period 1985-2003 and whose diagnoses were confirmed in a pathology review (n = 446). Controls were selected randomly from Group Health membership files and were matched to the cases by age and enrollment status at the reference date. An increased risk of EH was associated with increasing body mass index and nulliparity. There was a suggestion of a decreased risk of EH with atypia among current smokers. No association with diabetes or hypertension was found. The risk factors observed to be associated with EH in this study are similar to those associated with endometrial cancer. Whether these risk factors predispose women to cancer simply by increasing EH incidence or continue to augment cancer risk even after EH is present is currently unknown.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682485      PMCID: PMC2727194          DOI: 10.1093/aje/kwn168

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  38 in total

1.  Estrogen-induced uterine responses and growth: relationship to receptor estrogen binding by uterine nuclei.

Authors:  J N Anderson; E J Peck; J H Clark
Journal:  Endocrinology       Date:  1975-01       Impact factor: 4.736

2.  Hysterectomy surveillance--United States, 1980-1993.

Authors:  L A Lepine; S D Hillis; P A Marchbanks; L M Koonin; B Morrow; B A Kieke; L S Wilcox
Journal:  MMWR CDC Surveill Summ       Date:  1997-08-08

3.  Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase.

Authors:  B M Sherman; S G Korenman
Journal:  J Clin Endocrinol Metab       Date:  1974-07       Impact factor: 5.958

4.  The impact of bariatric surgery on menstrual patterns.

Authors:  Melissa Teitelman; Chad A Grotegut; Noel N Williams; James D Lewis
Journal:  Obes Surg       Date:  2006-11       Impact factor: 4.129

5.  An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding.

Authors:  C M Farquhar; A Lethaby; M Sowter; J Verry; J Baranyai
Journal:  Am J Obstet Gynecol       Date:  1999-09       Impact factor: 8.661

6.  Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations.

Authors:  Jessica Chubak; Shelley S Tworoger; Yutaka Yasui; Cornelia M Ulrich; Frank Z Stanczyk; Anne McTiernan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-08       Impact factor: 4.254

7.  Diagnosing endometrial hyperplasia: why is it so difficult to agree?

Authors:  Kimberly H Allison; Susan D Reed; Lynda F Voigt; Carolyn D Jordan; Kathryn M Newton; Rochelle L Garcia
Journal:  Am J Surg Pathol       Date:  2008-05       Impact factor: 6.394

8.  Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia.

Authors:  M F Janicek; N B Rosenshein
Journal:  Gynecol Oncol       Date:  1994-03       Impact factor: 5.482

9.  The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients.

Authors:  R J Kurman; P F Kaminski; H J Norris
Journal:  Cancer       Date:  1985-07-15       Impact factor: 6.860

10.  Spontaneous endometrial hyperplasia. A prospective, 5 year follow-up of 246 patients after abrasio only, including 380 patients followed-up for 2 years.

Authors:  B Lindahl; R Willén
Journal:  Anticancer Res       Date:  1994 Sep-Oct       Impact factor: 2.480

View more
  17 in total

1.  Incidence of endometrial hyperplasia.

Authors:  Susan D Reed; Katherine M Newton; Walter L Clinton; Meira Epplein; Rochelle Garcia; Kimberly Allison; Lynda F Voigt; Noel S Weiss
Journal:  Am J Obstet Gynecol       Date:  2009-04-23       Impact factor: 8.661

2.  Obesity adversely affects serum anti-müllerian hormone (AMH) levels in Caucasian women.

Authors:  Vicky Moy; Sangita Jindal; Harry Lieman; Erkan Buyuk
Journal:  J Assist Reprod Genet       Date:  2015-07-21       Impact factor: 3.412

3.  Factors associated with Type I and Type II endometrial cancer.

Authors:  Ashley S Felix; Joel L Weissfeld; Roslyn A Stone; Robert Bowser; Mamatha Chivukula; Robert P Edwards; Faina Linkov
Journal:  Cancer Causes Control       Date:  2010-07-14       Impact factor: 2.506

4.  Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study.

Authors:  Mia M Gaudet; Roni T Falk; Robert D Stevens; Marc J Gunter; James R Bain; Ruth M Pfeiffer; Nancy Potischman; Jolanta Lissowska; Beata Peplonska; Louise A Brinton; Montserrat Garcia-Closas; Christopher B Newgard; Mark E Sherman
Journal:  J Clin Endocrinol Metab       Date:  2012-06-22       Impact factor: 5.958

5.  Obesity and Endometrial Cancer: A Lack of Knowledge but Opportunity for Intervention.

Authors:  Ashley F Haggerty; David B Sarwer; Kathryn H Schmitz; Emily M Ko; Kelly C Allison; Christina S Chu
Journal:  Nutr Cancer       Date:  2017-09-22       Impact factor: 2.900

6.  Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy.

Authors:  Susan D Reed; Katherine M Newton; Rochelle L Garcia; Kimberly H Allison; Lynda F Voigt; C Diana Jordan; Meira Epplein; Elizabeth Swisher; Kristen Upson; Kelly J Ehrlich; Noel S Weiss
Journal:  Obstet Gynecol       Date:  2010-08       Impact factor: 7.661

7.  Effectiveness of progestin-based therapy for morbidly obese women with complex atypical hyperplasia.

Authors:  Marcia A Ciccone; Stephanie A Whitman; Charlotte L Conturie; Niquelle Brown; Christina E Dancz; Begum Özel; Koji Matsuo
Journal:  Arch Gynecol Obstet       Date:  2019-01-31       Impact factor: 2.344

8.  The use of novel technology-based weight loss interventions for obese women with endometrial hyperplasia and cancer.

Authors:  Ashley F Haggerty; Sarah Huepenbecker; David B Sarwer; Jacqueline Spitzer; Greer Raggio; Christina S Chu; Emily Ko; Kelly C Allison
Journal:  Gynecol Oncol       Date:  2015-11-28       Impact factor: 5.482

9.  Prevalence of Co-existing Endometrial Carcinoma in Patients with Preoperative Diagnosis of Endometrial Hyperplasia.

Authors:  Pinar Kadirogullari; Cemal Resat Atalay; Ozhan Ozdemir; Mustafa Erkan Sari
Journal:  J Clin Diagn Res       Date:  2015-10-01

10.  Factors associated with endometrial cancer and hyperplasia among middle-aged and older Hispanics.

Authors:  Ana M Rodriguez; Efstathia Polychronopoulou; Enshuo Hsu; Rahul Shah; Kelly Lamiman; Yong-Fang Kuo
Journal:  Gynecol Oncol       Date:  2020-11-19       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.